Technical Analysis for ABOS - Acumen Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 7.315 -2.98% -0.23
ABOS closed up 1.07 percent on Tuesday, December 7, 2021, on 2.03 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical ABOS trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction -2.98%
Wide Bands Range Expansion -2.98%
Oversold Stochastic Weakness -2.98%
New 52 Week Closing Low Bearish -1.94%
Volume Surge Other -1.94%
New 52 Week Low Weakness -1.94%
Wide Bands Range Expansion -1.94%
Oversold Stochastic Weakness -1.94%
1,2,3 Retracement Bearish Bearish Swing Setup -6.34%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -6.34%
Older End-of-Day Signals for ABOS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% 22 minutes ago
Down 2 % 22 minutes ago
Down 1% 22 minutes ago
Rose Above Previous Day's High 33 minutes ago
Up 3% 33 minutes ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapeutics for the treatment of Alzheimer's and other neurodegenerative diseases. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, which is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is based in Charlottesville, Virginia.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Biology Immunotherapy Alzheimer's Disease Neurodegenerative Diseases Neurodegeneration Amyloid Amyloidosis Regulus Therapeutics Targeted Immunotherapy Treatment Of Alzheimer's Amyloid Beta

Is ABOS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.98
52 Week Low 7.11
Average Volume 68,078
200-Day Moving Average 0.00
50-Day Moving Average 12.60
20-Day Moving Average 9.96
10-Day Moving Average 8.08
Average True Range 0.88
ADX 44.69
+DI 8.62
-DI 30.35
Chandelier Exit (Long, 3 ATRs) 12.46
Chandelier Exit (Short, 3 ATRs) 9.76
Upper Bollinger Bands 14.54
Lower Bollinger Band 5.39
Percent B (%b) 0.23
BandWidth 91.78
MACD Line -1.66
MACD Signal Line -1.54
MACD Histogram -0.1112
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.29
Resistance 3 (R3) 8.28 8.01 8.17
Resistance 2 (R2) 8.01 7.82 8.02 8.12
Resistance 1 (R1) 7.78 7.70 7.79 7.79 8.08
Pivot Point 7.51 7.51 7.52 7.52 7.51
Support 1 (S1) 7.28 7.32 7.29 7.29 7.00
Support 2 (S2) 7.01 7.20 7.02 6.96
Support 3 (S3) 6.78 7.01 6.92
Support 4 (S4) 6.79